vyne stock forecast zacks

Zacks Investment Research upgraded shares of VYNE Therapeutics NASDAQVYNE from a sell rating to a hold rating in a report published on Thursday morning. On average they anticipate the companys share price to reach 150 in the next twelve months.

Vyne Therapeutics Nasdaqcm Vyne Share Price News Analysis Simply Wall St

Their VYNE share price forecasts range from 150 to 150.

. VYNE stock price quote with breaking news financials statistics charts and more. According to 1 Wall Street analyst that have issued a 1 year VYNE price target the average VYNE price target is 150 with the highest VYNE stock price forecast at 150 and the lowest VYNE. Click here - the VYNE analysis is.

VYNE Stock Price Prediction. 43918 Upside Based on 2 Wall Street analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months. VYNE Therapeutics broker recommendation chart.

VYNE Therapeutics Stock Forecast VYNE stock price prediction. Get the most up-to-date stock earnings and estimate revisions from Zacks Investment Research. The best long-term short-term VYNE Therapeutics share price prognosis for 2022 2023.

VYNE stock quote history news and other vital information to help you with your stock trading and investing. VYNE stock returns are also predicted based on historical data. Get The Latest VNE Stock Forecast Price Target Earnings Estimates Headlines Short Interest at MarketBeat.

In fact when combining a Zacks Rank 3 or better and a positive Earnings ESP stocks produced a positive surprise 70 of the time while they also saw 283 annual returns. In fact when combining a Zacks Rank 3 or better and a positive Earnings ESP stocks produced a positive surprise 70 of the time while they also saw 283 annual returns on average. According to 11 stock analysts the average 12-month stock price forecast for VYNE stock is 479 which predicts an increase of 160645.

Zacks Investment Research is releasing its prediction for VYNE based on the 1-3 month trading system that more than doubles the SP 500. Stock Price Forecast. VYNE might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank 2 Buy.

Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the VYNE shares relative to the. Find the latest VYNE Therapeutics Inc. Get the latest chart with broker recommendations from Zacks Investment Research.

Get a real-time VYNE Therapeutics Inc. The average price target is. Price target in 14 days.

Zacks proprietary data indicates that VYNE Therapeutics Inc. Find out the current price target and stock forecast for VYNE Therapeutics VYNE. VYNE Therapeutics Inc.

The 3 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 400 with a high estimate of 500 and a low estimate of 150.

50 Biggest Movers From Friday Markets Insider